GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;

Crwewallstreet Newsletter

__ GLG Life Tech Corporation (Nasdaq:GLGL) (TSX:GLG) (“GLG” or the “Company”), the vertically-integrated leader in the agricultural and commercial development of high quality stevia, announces the commencement of production of four beverage products by its joint venture partner China and Healthy Foods Company Limited (CAHFC) for the ANOCTM business in China.

The production line was constructed during the third quarter at CAHFC`s Xioagang facility and is capable of producing 108 million 500ml servings per year. The new facility will initially produce four beverage products: Green Tea, Black Tea, Peach Juice and Orange Juice. All products are part of the new ANOCTM product line and are sweetened with stevia. The grand opening ceremony for this new line took place on December 17, 2010 with a strong showing of local and provincial Government officials. Most notably, Vice Governor Honorable Mr. Zhao, Shucong and Party Secretary of Chuzhou City Honorable Mr. Han, Xiancong of the Anhui Province attended the ceremony and were present to receive the first bottle of ANOCTM beverage from the new production line. One of the key government objectives is to demonstrate that a rural farming region such as Xioagang can not only support strong farming economy but also industrial development that will further increase the economic prosperity for a rural region. Xioagang is demonstrating this through stevia farming and the use of stevia extracts in consumer products also produced in the Xioagang region. The Xioagang example is expected to be a model for other China rural areas to follow.

GLG Chairman and CEO Dr. Luke Zhang stated: “The grand opening of this new facility marks an important milestone for the ANOC joint venture. We can now develop the inventory necessary for our first ANOCTM beverage product launch in 2011. GLG and CAHFC control every step now from seed to shelf for consumer products including quality control and product formulation. We are proud of our partner`s achievement and we can now focus on the rollout of our first four beverage products in the first quarter of 2011. GLG also recognizes CAHFC`s achievement towards the development of value added industry in the Xioagang region to the stevia crop grown in Xioagang.” China`s food and beverage industry has experienced a more than 20% annual growth rate from 2002 to 2009 with the industry growing from approximately RMB900 billion to RMB4.7 trillion (US$ 693 billion) in 2009. As China`s middle class continues to develop, this is expected to fuel consumption growth in the China beverage and food industry. The Freedonia Group estimates that the China beverage market will grow from 105,750 million liters in 2007 to 199,500 million liters in 2017.

GLG also sees issues relating to obesity and diabetes in China as important for the joint venture`s products. China became the world`s second largest country, in terms of the number of diabetic patients (India is largest), with 92 million cases reported in 2009 (up from 10 million in 1987). China`s Ministry of Health has also reported that there are currently 350 million people considered overweight and 70 million people considered obese. Adult Chinese male obesity patients are currently increasing at approximately 1.2% every year, surpassing the obesity growth rates in the USA, UK and Australia.

ANOC plans to launch its initial products in the first quarter of 2011 through a number of national distribution channels which have been recruited by CAHFC in the past six months, as well as through a network of 600 ANOCTM stores in major cities that have also been developed in 2009 by CAHFC.

About GLGL:

GLG Life Tech Corporation is a global leader in the supply of high purity stevia extracts, an all natural, zero-calorie sweetener used in food and beverages. The Company`s vertically integrated operations cover each step in the stevia supply chain including non-GMO stevia seed breeding, natural propagation, stevia leaf growth and harvest, proprietary extraction and refining, marketing and distribution of finished product. GLG`s advanced technology, extraction technique and premier, high quality product offerings make it a leading producer of high purity, great tasting stevia extracts.

More about GLGL at: www.glglifetech.com Orofino Gold Corp. (ORFG.PK) (“Orofino Gold” or the “Company”) has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.

The company newly announced that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director.

Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of Orofino Gold Corp. (see full resume on the company website at www.orofinogold.com) Mr. Pernett will be responsible for all affairs of the Company in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of the company`s Senderos de Oro gold camp in the Sur de Bolivar Colombia.

The company and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, the company`s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past. The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.

The Board of Director`s have accepted resignation of John T. Martin, former Managing Director of the Company. His resignation is effective immediately. The Company wish him well and success in future endeavors.

La Azul – Senderos de Oro Area La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.

It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable “hidden porphyry” exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino “qualified person” as per the 43-101 rules.

Orofino will move ahead aggressively in the last quarter of 2010 to persue the current interpretations, work programs and drilling will begin soon.

San Carlos – Senderos de Oro Area Geologically similar to Angostura and Ventana but higher grade, open at depth and to the west toward La Azul.

The observed metallogenic zonation around Senderos de Oro evokes a very viable “hidden porphyry” exploration model. Based upon exploration carried out to date, it is clear that the area hosts significant resources of gold, copper and silver, which, facilitated by the current database and favorable topography, has generated excellent “fast-trackable” bulk-tonnage or high-grade underground Au-Ag-Cu exploration targets.

Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. The company has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. Orofino Gold Corp. was formerly known as SNT Cleaning, Inc. and changed its name to Orofino Gold Corp. in December 2009. The company was founded in 2005 and is based in Central, Hong Kong.

More about ORFG at:www.orofinogold.com Power3 Medical Products Inc (OTCBB:PWRM.OB), a development stage company, engages in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, amyotrophic lateral sclerosis (ALS), Alzheimer`s disease, and Parkinson`s disease.

PWRM has delivered four poster presentations at the 2010 International Conference on Alzheimers Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3s diagnostic test, and focused on PWRM s Alzheimers disease blood serum biomarkers, test and clinical validation trials.

President and Chief Scientific Officer of Power3,Dr. Ira L. Goldknopf, commented: In preparation for commercialization, our objective at this meeting was to show how Power3s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimers disease. It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which PWRMs protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.

Alzheimer`s disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer`s diseases is the reason for 50 to seventy per cent of dementia cases.

Breast cancer (malignant breast neoplasm) is actually cancer originating from breast tissue, most commonly of your intrinsic lining of milk ducts as well as lobules that offer the ducts with milk. Cancers caused by ducts are classified as ductal carcinomas; individuals originating from lobules are classified as lobular carcinomas.

PWRM has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro protein biomarkers in the blood of untreated Alzheimers disease patients compared to patients treated with the widely used anti-dementia drugs Aricept (Donepezil HCl, Pfizer NYSE: PFE), Exelon (Rivastigmine, Novartis NYSE: NVS), and Namenda (Memantine HCl, Forest Laboratories NYSE: FRX). These results relate to the genetically distinct groups of Alzheimers disease patients, i.e., those individuals who possess the Alzheimers high-risk gene for Apolipoprotein E4 and those who do not possess the gene.

More about PWRM at: www.Power3Medical.com ************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(_Read more at_ http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

— The following information is a reminder of your current mailing list subscription:

You are subscribed to the following list:

Crwewallstreet.com

Related posts:

1. GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;
2. GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;
3. GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;
4. GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;
5. GLGL, ORFG, PWRM – GLG Life Tech, Orofino Gold, Power3 Medical;